Literature DB >> 3961818

Elimination kinetics of 2-butoxyethanol in the perfused rat liver--dose dependence and effect of ethanol.

G Johanson, M Wallén, M Byfält Nordqvist.   

Abstract

The elimination kinetics of 2-butoxyethanol (ethylene glycol monobutyl ether, EGBE) were studied in the once-through isolated perfused rat liver system in the presence and absence of ethanol. Dose-dependent Michaelis-Menten kinetics in the elimination of EGBE were observed in the investigated concentration range. The apparent Michaelis constant range from 0.32 to 0.70 mM while the maximum elimination rate ranged from 0.63 to 1.4 mumol/min/g liver (parallel tube model) in six different experiments. The maximum intrinsic clearance varied between 0.7 and 2.0 ml/min/g liver. In the presence of 17.1 mM ethanol (0.1%) the extraction ratio of EGBE decreased from 0.44 to 0.11. The results support the hypothesis that EGBE is mainly metabolized via oxidation by alcohol dehydrogenase in the rat liver. The concentration dependence occurred at plausible in vivo doses.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3961818     DOI: 10.1016/0041-008x(86)90308-x

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  4 in total

1.  Experimental human exposure to ethylene glycol monomethyl ether.

Authors:  D Groeseneken; H Veulemans; R Masschelein; E Van Vlem
Journal:  Int Arch Occup Environ Health       Date:  1989       Impact factor: 3.015

2.  Inhalation toxicokinetics of butoxyethanol and its metabolite butoxyacetic acid in the male Sprague-Dawley rat.

Authors:  G Johanson
Journal:  Arch Toxicol       Date:  1994       Impact factor: 5.153

3.  2-Butoxyethanol autoprotection is due to resiliance of newly formed erythrocytes to hemolysis.

Authors:  D V Sivarao; H M Mehendale
Journal:  Arch Toxicol       Date:  1995       Impact factor: 5.153

4.  A framework incorporating the impact of exposure scenarios and application conditions on risk assessment of chemicals applied to skin.

Authors:  Yuri Dancik; John A Troutman; Joanna Jaworska
Journal:  In Silico Pharmacol       Date:  2013-06-14
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.